Intake of Omega 3 in Morbidly Obese Patients

NACompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

June 30, 2014

Study Completion Date

July 31, 2014

Conditions
Morbid Obesity
Interventions
DIETARY_SUPPLEMENT

Omega 3 intake, morbid obesity

Individuals of both sexes with ages between 18 and 65 years took 3g of omega 3, and 1.8g eicosapentaenoic acid (EPA) and 1.2g docosahexanoic acid (DHA) for 8 weeks.

DIETARY_SUPPLEMENT

Placebo Capsules

They received gelatin (colorless) capsules. A nutritional evaluation was performed, a 24-h recordatory was applied to verify macro and micronutrients intake, biochemical evaluation before and after the intervention. Macro and micronutrients were calculated using the Avanutri 2.0 system. Clinical history was verified through a questionnaire previously filled out by a physician.

All Listed Sponsors
lead

Pontificia Universidade Católica do Rio Grande do Sul

OTHER

NCT02113696 - Intake of Omega 3 in Morbidly Obese Patients | Biotech Hunter | Biotech Hunter